The Bulletin
The Times


.

Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine

  • Written by The Bulletin

Encouraging findings with immunotherapy aiming at ART-free virological control A significant step towards functional cure of HIV infection

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce the completion of a first-in-human novel therapeutic HIV vaccine, ICVAX, Phase I clinical trial with encouraging findings of exceptional safety and promising immunogenicity profiles.

Read more: Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA...

hacklink hack forum hacklink film izle hacklink Padişahbetjojobetjojobetcasino siteleriPadişahbetDizipalPadişahbetGalabetTuloskeskusjojobetjojobetcasibomjojobetesim balkancasibom girismarsbahis girişwww.jmctpolytechnic.orgbetparkbetparkonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline pokieGalabetThe Pokies casinoplay pokies onlineonline pokiesbest pokies sitesThe Pokies reviewThe Pokies loginThe Pokies bonuspokies onlineAustralian pokiesreal money pokiesankara escortz-libjojobetcasinomilyonjojobetholiganbet